Ropes & Gray advised Genesis Therapeutics on the transaction. Genesis Therapeutics (Nasdaq: GILD) announced it has entered into a strategic collaboration with Gilead Sciences, Inc. to...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell is advising Gilead Sciences, Inc. on the transaction, and Cravath, Swaine & Moore is advising CymaBay Therapeutics, Inc. Gilead Sciences, Inc. (Gilead)...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Assembly Bio on the transaction, and Ropes & Gray advised Gilead Sciences, Inc. Assembly Biosciences (Nasdaq: ASMB) and Gilead Sciences (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Proskauer and Kirkland & Ellis secured a decisive victory for Gilead Sciences, Inc. in a $3.6 billion antitrust case on allegations that the pharmaceutical company struck...
You must be a Standard 1 Year member to access this content.
Patterson Belknap Webb & Tyler represented Gilead in the case. A Florida federal judge sentenced Lazaro Hernandez to 15 years for allegedly distributing over $230 million...
You must be a Standard 1 Year member to access this content.
WilmerHale advised Gilead Sciences on the deal. Gilead Sciences obtained a landmark victory on May 9, 2023 when a federal jury sided with the pharmaceutical company against the...
You must be a Standard 1 Year member to access this content.
Patterson Belknap Webb & Tyler advised the plaintiffs on the case. Gilead Sciences had filed a lawsuit against several healthcare clinics, pharmacies, prescribers, and lab testing facilities for...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell, Mayer Brown, and Mishcon de Reya advised Gilead, while Goodwin Procter and Wilson Sonsini Goodrich & Rosati advised MiroBio on the deal....
You must be a Standard 1 Year member to access this content.
Hogan Lovells has advised Gilead Sciences, Inc. on the deal. Gilead Sciences, Inc. entered into a strategic research collaboration with Dragonfly Therapeutics, a clinical-stage biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Hogan Lovells has advised Gilead Sciences, Inc. on the deal. Gilead Sciences, Inc. entered into a strategic research collaboration with Dragonfly Therapeutics, a clinical-stage biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Hogan Lovells and White & Case, LLP acted as legal counsel to Gilead. Morgan, Lewis & Bockius and Gibson Dunn advised Merck. Gilead Sciences, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
